Unlocking Cardiovascular Potential: Presenting the Latest Evidence Supporting Positive Outcomes with GLP-1s
Time: 9:00 am
day: Conference Day One
Details:
- Exploring evidence supporting positive cardiovascular outcomes of GLP-1s to reveal the possibility of a cardiovascular market for therapies
- Considering approaches, including the use of agonist combinations, to gain positive cardiovascular outcomes
- Navigating potential challenges that may arise in the context of employing GLP-1 treatments for cardiovascular indications
